{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,7]],"date-time":"2026-08-07T16:04:58Z","timestamp":1786118698078,"version":"build-2736575974"},"reference-count":34,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"4","funder":[{"DOI":"10.13039\/100000026","name":"National Institute on Drug Abuse","doi-asserted-by":"crossref","award":["K23DA048169"],"award-info":[{"award-number":["K23DA048169"]}],"id":[{"id":"10.13039\/100000026","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":["J Dev Behav Pediatr"],"published-print":{"date-parts":[[2025,7]]},"abstract":"<jats:title>ABSTRACT:<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Objective:<\/jats:title>\n                    <jats:p>Describe the engagement of opioid-exposed infants (OEI) with recommended developmental surveillance and supports in the first year of life.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods:<\/jats:title>\n                    <jats:p>We conducted a single-site retrospective cohort study of OEI delivered between 2016 and 2021, linking birth hospitalization, developmental follow-up (DFU) clinic, and early intervention (EI) records. Primary outcomes were attendance at DFU clinic and evaluation by EI. We used multivariable modified Poisson regression to examine how birthing parent-, infant-, and clinic-level factors are associated with service engagement.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results:<\/jats:title>\n                    <jats:p>Of 256 OEI, 75% engaged in at least 1 developmental service. Referral and attendance rates at the DFU clinic were 69% and 33%, respectively. Ninety-three percent were referred to EI, 73% evaluated and 58% enrolled in services. EI evaluation was positively associated with prolonged infant hospitalization (adjusted risk ratio [aRR] 1.01; CI, 1.002\u20131.01) and exposure to antidepressants (aRR 1.23; CI, 1.02\u20131.49) and cocaine (aRR 1.28; CI, 1.09\u20131.50). Probability of attendance at DFU was higher for infants born to parents receiving care at an integrated perinatal substance use clinic (aRR 2.13; CI, 1.07\u20134.24) and exposed to antipsychotics (aRR 1.73; CI, 1.12\u20132.67), whereas those remaining in parental custody had lower probability of engagement (aRR 0.62; CI, 0.39\u20130.97).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion:<\/jats:title>\n                    <jats:p>Three-quarters of the OEI engaged in developmental surveillance services in the first year of life. Factors relating to disease severity, location of birthing parent care, birthing parent co-exposures, and parental custody were associated with engagement. Efforts to improve engagement in recommended follow-up should elicit the perspectives of caregivers to better understand the mechanisms that drive these differences.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1097\/dbp.0000000000001372","type":"journal-article","created":{"date-parts":[[2025,7,2]],"date-time":"2025-07-02T17:00:12Z","timestamp":1751475612000},"page":"e375-e382","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":1,"title":["Engagement With Recommended Developmental Follow-up and Supports Among Infants With Intrauterine Opioid Exposure"],"prefix":"10.1097","volume":"46","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-1785-1202","authenticated-orcid":false,"given":"Margarida","family":"Mascarenhas","sequence":"first","affiliation":[{"name":"Department of Pediatrics, Jackson Memorial Hospital, Miami, FL;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elizabeth","family":"Peacock-Chambers","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, Baystate Health, Springfield, MA;"},{"name":"Department of Healthcare Delivery and Population Science, University of Massachusetts Chan Medical School-Baystate, Springfield, MA;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yarden S.","family":"Fraiman","sequence":"additional","affiliation":[{"name":"Department of Neonatology, Beth Israel Deaconess Medical Center, Boston, MA;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leslie S.","family":"Kerzner","sequence":"additional","affiliation":[{"name":"Department of Neonatology, MassGeneral for Children, Boston, MA;"},{"name":"Harvard Medical School, Boston, MA; and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Davida M.","family":"Schiff","sequence":"additional","affiliation":[{"name":"Division of General Academic Pediatrics, MassGeneral for Children, Boston, MA."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2025,6,24]]},"reference":[{"key":"R1-20260128","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1001\/jama.2020.24991","article-title":"Neonatal abstinence syndrome and maternal opioid-related diagnoses in the US, 2010-2017","volume":"325","author":"Hirai","year":"2021","journal-title":"JAMA"},{"key":"R2-20260128","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1038\/jp.2015.63","article-title":"Increasing incidence and geographic distribution of neonatal abstinence syndrome: United States 2009 to 2012","volume":"35","author":"Patrick","year":"2015","journal-title":"J Perinatol"},{"key":"R3-20260128","doi-asserted-by":"crossref","first-page":"706","DOI":"10.1001\/jamapediatrics.2020.6364","article-title":"Infant mortality associated with prenatal opioid exposure","volume":"175","author":"Leyenaar","year":"2021","journal-title":"JAMA Pediatr"},{"key":"R4-20260128","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1038\/s41372-018-0088-9","article-title":"Retrospective review of neurodevelopmental outcomes in infants treated for neonatal abstinence syndrome","volume":"38","author":"Merhar","year":"2018","journal-title":"J Perinatol"},{"key":"R5-20260128","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.earlhumdev.2014.10.006","article-title":"Infants of opioid-dependent mothers: neurodevelopment at six months","volume":"91","author":"McGlone","year":"2015","journal-title":"Early Hum Dev"},{"key":"R6-20260128","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.earlhumdev.2007.01.013","article-title":"Adverse neurodevelopmental outcome of infants exposed to opiate in-utero","volume":"84","author":"Hunt","year":"2008","journal-title":"Early Hum Dev"},{"key":"R7-20260128","doi-asserted-by":"crossref","first-page":"e20162651","DOI":"10.1542\/peds.2016-2651","article-title":"Neonatal abstinence syndrome and high school performance","volume":"139","author":"Oei","year":"2017","journal-title":"Pediatrics"},{"key":"R8-20260128","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1097\/DBP.0000000000000711","article-title":"Health and neurodevelopment of children born to opioid-dependent mothers at school entry","volume":"41","author":"Lee","year":"2020","journal-title":"J Dev Behav Pediatr"},{"key":"R9-20260128","doi-asserted-by":"crossref","first-page":"e20190514","DOI":"10.1542\/peds.2019-0514","article-title":"Cognitive and behavioral impact on children exposed to opioids during pregnancy","volume":"144","author":"Larson","year":"2019","journal-title":"Pediatrics"},{"key":"R10-20260128","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1016\/S2352-4642(24)00076-2","article-title":"School performance in children with prenatal drug exposure and out-of-home care in NSW, Australia: a retrospective population-based cohort study","volume":"8","author":"Uebel","year":"2024","journal-title":"Lancet Child Adolesc Health"},{"key":"R11-20260128","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/S0378-4274(02)00505-2","article-title":"The impact of intrauterine exposure versus postnatal environment in neurodevelopmental toxicity: long-term neurobehavioral studies in children at risk for developmental disorders","volume":"140-141","author":"Ornoy","year":"2003","journal-title":"Toxicol Lett."},{"key":"R12-20260128","doi-asserted-by":"crossref","first-page":"e2020029074","DOI":"10.1542\/peds.2020-029074","article-title":"Neonatal opioid withdrawal syndrome","volume":"146","author":"Patrick","year":"2020","journal-title":"Pediatrics"},{"key":"R13-20260128","doi-asserted-by":"crossref","first-page":"e20191275","DOI":"10.1542\/peds.2019-1275","article-title":"Well-child care adherence after intrauterine opioid exposure","volume":"145","author":"Goyal","year":"2020","journal-title":"Pediatrics"},{"key":"R14-20260128","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1016\/j.jpeds.2018.03.012","article-title":"Primary care and home visiting utilization patterns among at-risk infants","volume":"198","author":"Goyal","year":"2018","journal-title":"J Pediatr"},{"key":"R16-20260128","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1097\/DBP.0000000000000679","article-title":"Early intervention referral and enrollment among infants with neonatal abstinence syndrome","volume":"40","author":"Peacock-Chambers","year":"2019","journal-title":"J Dev Behav Pediatr."},{"key":"R17-20260128","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1097\/DBP.0000000000000474","article-title":"Social disparities in early intervention service use and provider-reported outcomes","volume":"38","author":"Khetani","year":"2017","journal-title":"J Dev Behav Pediatr."},{"key":"R18-20260128","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1097\/DBP.0b013e3182142fbd","article-title":"The impact of race on participation in part C early intervention services","volume":"32","author":"Feinberg","year":"2011","journal-title":"J Dev Behav Pediatr"},{"key":"R19-20260128","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1007\/s10995-007-0227-y","article-title":"Using linked data to assess patterns of Early Intervention (EI) referral among very low birth weight infants","volume":"12","author":"Barfield","year":"2008","journal-title":"Matern Child Health J."},{"key":"R20-20260128","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1007\/s10995-006-0080-4","article-title":"Birth characteristics associated with early intervention referral, evaluation for eligibility, and program eligibility in the first year of life","volume":"10","author":"Clements","year":"2006","journal-title":"Matern Child Health J"},{"key":"R21-20260128","doi-asserted-by":"crossref","first-page":"842","DOI":"10.1542\/peds.2014-3299","article-title":"Prescription opioid epidemic and infant outcomes","volume":"135","author":"Patrick","year":"2015","journal-title":"Pediatrics"},{"key":"R22-20260128","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1007\/s10995-016-2190-y","article-title":"The prevalence and impact of substance use disorder and treatment on maternal obstetric experiences and birth outcomes among singleton deliveries in Massachusetts","volume":"21","author":"Kotelchuck","year":"2017","journal-title":"Matern Child Health J"},{"key":"R23-20260128","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1038\/s41372-021-01188-2","article-title":"Race, language, and neighborhood predict high-risk preterm Infant Follow up Program participation","volume":"42","author":"Fraiman","year":"2022","journal-title":"J Perinatol"},{"key":"R24-20260128","first-page":"141","article-title":"Neonatal abstinence syndrome: assessment and management","volume":"2","author":"Finnegan","year":"1975","journal-title":"Addict Dis"},{"key":"R25-20260128","doi-asserted-by":"crossref","first-page":"e20163360","DOI":"10.1542\/peds.2016-3360","article-title":"An initiative to improve the quality of care of infants with neonatal abstinence syndrome","volume":"139","author":"Grossman","year":"2017","journal-title":"Pediatrics"},{"key":"R26-20260128","doi-asserted-by":"crossref","first-page":"1948","DOI":"10.1377\/hlthaff.2014.0679","article-title":"The child opportunity index: improving collaboration between community development and public health","volume":"33","author":"Acevedo-Garcia","year":"2014","journal-title":"Health Aff (Millwood)"},{"key":"R28-20260128","doi-asserted-by":"crossref","first-page":"e20191957","DOI":"10.1542\/peds.2019-1957","article-title":"Engagement in early intervention services among mothers in recovery from opioid use disorders","volume":"145","author":"Peacock-Chambers","year":"2020","journal-title":"Pediatrics"},{"key":"R29-20260128","doi-asserted-by":"crossref","first-page":"706","DOI":"10.1097\/DBP.0000000000000494","article-title":"Reason for referral predicts utilization and perceived impact of early intervention services","volume":"38","author":"Javalkar","year":"2017","journal-title":"J Dev Behav Pediatr"},{"key":"R30-20260128","doi-asserted-by":"crossref","first-page":"e287","DOI":"10.1097\/pq9.0000000000000287","article-title":"Optimizing high-risk infant follow-up in nonresearch-based paradigms: the new england follow-up network","volume":"5","author":"Litt","year":"2020","journal-title":"Pediatr Qual Saf."},{"key":"R31-20260128","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1159\/000260136","article-title":"Neurodevelopmental outcome of extremely low birth weight infants from the Vermont oxford network: 1998\u20132003","volume":"97","author":"Mercier","year":"2010","journal-title":"Neonatology"},{"key":"R32-20260128","doi-asserted-by":"crossref","first-page":"113971","DOI":"10.1016\/j.jpeds.2024.113971","article-title":"Challenges and opportunities in high-risk infant follow-up: progress from the 2022 networking session at the pediatric academic societies","volume":"270","author":"Neel","year":"2024","journal-title":"J Pediatr"},{"key":"R33-20260128","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1097\/AOG.0000000000002734","article-title":"Fatal and nonfatal overdose among pregnant and postpartum women in Massachusetts","volume":"132","author":"Schiff","year":"2018","journal-title":"Obstet Gynecol"},{"key":"R34-20260128","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/j.drugalcdep.2018.07.024","article-title":"Impact of psychiatric medication co-exposure on Neonatal Abstinence Syndrome severity","volume":"192","author":"Wachman","year":"2018","journal-title":"Drug Alcohol Depend"},{"key":"R35-20260128","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1177\/0009922813477237","article-title":"Factors associated with neonatal intensive care follow-up appointment compliance","volume":"52","author":"Harmon","year":"2013","journal-title":"Clin Pediatr (Phila)"},{"key":"R36-20260128","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1111\/cch.12015","article-title":"Maternal and infant predictors of attendance at Neonatal Follow-Up programmes","volume":"40","author":"Ballantyne","year":"2014","journal-title":"Child Care Health Dev"}],"container-title":["Journal of Developmental &amp; Behavioral Pediatrics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.1097\/DBP.0000000000001372","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,6]],"date-time":"2026-08-06T16:29:53Z","timestamp":1786033793000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.1097\/DBP.0000000000001372"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6,24]]},"references-count":34,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2025]]}},"URL":"https:\/\/doi.org\/10.1097\/dbp.0000000000001372","relation":{},"ISSN":["1536-7312"],"issn-type":[{"value":"1536-7312","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,6,24]]},"assertion":[{"value":"2024-07-18","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-03-04","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}